pentylenetetrazole has been researched along with Benign Frontal Childhood Epilepsy in 1 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhu, G | 1 |
Okada, M | 1 |
Yoshida, S | 1 |
Ueno, S | 1 |
Mori, F | 1 |
Takahara, T | 1 |
Saito, R | 1 |
Miura, Y | 1 |
Kishi, A | 1 |
Tomiyama, M | 1 |
Sato, A | 1 |
Kojima, T | 1 |
Fukuma, G | 1 |
Wakabayashi, K | 1 |
Hase, K | 1 |
Ohno, H | 1 |
Kijima, H | 1 |
Takano, Y | 1 |
Mitsudome, A | 1 |
Kaneko, S | 1 |
Hirose, S | 1 |
1 other study available for pentylenetetrazole and Benign Frontal Childhood Epilepsy
Article | Year |
---|---|
Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype.
Topics: Age Factors; Analysis of Variance; Animals; Behavior, Animal; Cerebral Cortex; Dose-Response Relatio | 2008 |